Agios Pharmaceuticals reported $0 in EBITDA for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acceleron Pharma XLRN:US $ -18M 33M
Alexion Pharmaceuticals ALXN:US $ 777.5M 44.6M
Alnylam Pharmaceuticals ALNY:US $ -216.63M 25.97M
Amgen AMGN:US $ 3253M 1M
AstraZeneca AZN:LN 2236M 118M
Bayer BAYN:GR € 2780M 1635M
Biogen BIIB:US $ 1293.5M 829.7M
Biomarin Pharmaceutical BMRN:US $ -16.91M 85.25M
Bluebird Bio BLUE:US $ -23.05M 178.6M
Bristol Myers Squibb BMY:US $ 4210M 401M
Daiichi Sankyo 4568:JP Y 48242M 51610M
Eli Lilly And LLY:US $ 1763M 213.6M
Exelixis EXEL:US $ 77M 23M
Gilead Sciences GILD:US $ -2633M 5384M
GlaxoSmithKline GSK:LN 1750M 932M
Immunogen IMGN:US $ -16.2M 0.94M
JAZZ PHA JAZZ:US $ 267.7M 1.86M
Merk MRK:US $ 4770M 728M
Novartis NVS:US $ 5060M 440M
Pfizer PFE:US $ 5103M 939M
Puma Biotechnology PBYI:US $ 9M 22M
Regeneron Pharmaceuticals REGN:US $ 715.2M 41M
Sarepta Therapeutics SRPT:US $ -132M 20M
Seattle Genetics SGEN:US $ 653.64M 732.26M
Vertex Pharmaceuticals VRTX:US $ 753.93M 5.28M
YTE INCY:US $ 262.67M 904.82M